Physician profile
Gary Thomas Collins
NPI 1396738373
$2,051.86
in general payments reported to CMS, 2019-2025
20 companies · $35.55 in 2025
The $35.55 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $626 · 2020: $83.83 · 2022: $141 · 2023: $573 · 2024: $593 · 2025: $35.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,201.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $555.51 | 2019-2024 | Jornay Pm |
| Corium, LLC | $381.90 | 2022-2024 | Azstarys |
| Glaxosmithkline, LLC. | $202.10 | 2022-2024 | Bexsero |
| Merck Sharp & Dohme LLC | $186.13 | 2019-2024 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Kaleo, INC. | $149.65 | 2023-2024 | Auvi-Q |
| Phadia US INC. | $148.12 | 2019-2024 | Immunocap |
| Supernus Pharmaceuticals, INC. | $86.85 | 2024-2025 | Qelbree |
| Cranial Technologies, INC | $50.69 | 2023-2024 | Doc Band |
| Tris Pharma INC | $47.40 | 2023-2025 | Dyanavel Xr |
| Pfizer INC. | $41.04 | 2019-2023 | |
| Sanofi Pasteur INC. | $37.75 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $37.00 | 2023-2024 | Flumist Quadrivalent |
| Biogen, INC. | $20.59 | 2024 | Skyclarys |
| Novartis Pharmaceuticals Corporation | $19.87 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.82 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $16.60 | 2019 | |
| Rhythm Pharmaceuticals, INC. | $16.43 | 2024 | Imcivree |
| Genentech USA, INC. | $13.87 | 2019 | |
| Sobi, INC | $12.36 | 2019 | |
| Sunovion Pharmaceuticals INC. | $11.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.